Fennec Pharmaceuticals (FENC) Finished Goods (2022 - 2025)

Fennec Pharmaceuticals (FENC) has 4 years of Finished Goods data on file, last reported at $1.6 million in Q4 2025.

• For the quarter ending Q4 2025, Finished Goods rose 47.64% year-over-year to $1.6 million; the trailing twelve-month figure through Dec 2025 stood at $1.6 million (up 47.64% YoY), and the FY2025 full-year result was $1.6 million, up 47.64% from the prior year.
• Finished Goods for Q4 2025 stood at $1.6 million, down from $2.5 million in the prior quarter.
• Across five years, Finished Goods topped out at $2.5 million in Q3 2025 and bottomed at $576000.0 in Q4 2022.
• The 4-year median for Finished Goods is $1.6 million (2025), against an average of $1.6 million.
• The widest annual swing landed in 2023, when Finished Goods surged 274.31%; it then plunged 50.83% in 2024.
• A 4-year view of Finished Goods shows it stood at $576000.0 in 2022, then soared by 274.31% to $2.2 million in 2023, then slumped by 50.83% to $1.1 million in 2024, then soared by 47.64% to $1.6 million in 2025.
• The last three Finished Goods figures came in at $1.6 million (Q4 2025), $2.5 million (Q3 2025), and $2.2 million (Q2 2025), per Business Quant data.

Peer Comparison